Key result
An automated machine learning pipeline using patient-level ECG profiles accurately detected pulmonary arterial hypertension (AUROC 0.94), hypertrophic cardiomyopathy (AUROC 0.91), and cardiac amyloidosis (AUROC 0.86).
Why the study?
Advances in computing, machine learning, and large-scale data may expand clinical inferences from the ECG while preserving interpretability for medical decision-making.
Do machine learning models using patient-level ECG profiles accurately estimate cardiac structure and detect cardiovascular diseases compared to standard clinical measurements?
Population
36 186 ECGs from the University of California, San Francisco database
Comparison
ECG-profile machine learning models vs clinical measurements
Authors
Loading...
May aid ECG-based detection of PAH, HCM, and amyloid; leaves open prospective validation before clinical adoption.
Observational (n=36,186)
No
Do machine learning models using patient-level ECG profiles accurately estimate cardiac structure and detect cardiovascular diseases compared to standard clinical measurements?
Effect estimate: AUROC 0.94 (95% CI 0.93-0.95)
Machine learning models applied to standard 12-lead ECGs can accurately estimate cardiac structure and detect specific cardiovascular diseases such as pulmonary arterial hypertension and hypertrophic cardiomyopathy.
Tison et al. (2019) conducted an observational in Normal sinus rhythm (n=36,186). ecgAI (CNN-HMM derived ECG segmentation and patient-level ECG profiles) vs. Clinical estimates (MUSE/echocardiogram) was evaluated on Detection of pulmonary arterial hypertension (PAH) (AUROC 0.94, 95% CI 0.93-0.95). An automated machine learning pipeline using patient-level ECG profiles accurately detected pulmonary arterial hypertension (AUROC 0.94), hypertrophic cardiomyopathy (AUROC 0.91), and cardiac amyloidosis (AUROC 0.86).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: